Stockholders' Equity - Preferred Stock (Details) $ in Millions |
9 Months Ended | ||
|---|---|---|---|
|
Dec. 28, 2022
USD ($)
shares
|
Sep. 28, 2024
shares
|
Dec. 30, 2023
shares
|
|
| Series A-1 Preferred | |||
| Shareholders Equity [Line Items] | |||
| Series A-1 preferred converted (in shares) | 170,250 | ||
| Preferred stock, outstanding shares (in shares) | 23,480 | 193,730 | |
| Series S Convertible Preferred Stock | |||
| Shareholders Equity [Line Items] | |||
| Preferred stock, outstanding shares (in shares) | 100,000 | 100,000 | |
| Preferred stock, conversion ratio | 1 | ||
| Series S Convertible Preferred Stock | Soin Therapeutics | |||
| Shareholders Equity [Line Items] | |||
| Issuance of shares of common stock to legacy equity holders | $ | $ 30.0 | ||
| Company tendered (in shares) | 100,000 |
| X | ||||||||||
- Definition Shareholders equity. No definition available.
|
| X | ||||||||||
- Definition Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of equity interests issued or issuable to acquire entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of common shares issuable upon conversion for each share of preferred stock to be converted. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares issued during the period as a result of the conversion of convertible securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|